Tag: Paige.AI
Computational pathology startup Paige.AI gets ‘Breakthrough Designation’ from FDA
The computational pathology startup Paige.AI has received 'Breakthrough Device' designation by the U.S. Food and Drug Administration (FDA)
Healthcare startup Paige.AI ropes in Leo Grady as CEO
Paige.AI was launched in 2018 based on technology developed by its Co-Founder and Chief Scientific Officer, Dr. Thomas Fuchs, and a license agreement with Memorial Sloan Kettering Cancer Center (MSK).
